Acrivon Therapeutics Share Price (NASDAQ: ACRV)
$1.35
▲
0.02
(1.5%)
Last updated on
Check the interactive Acrivon Therapeutics Stock chart to analyse performance
Acrivon Therapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$1.34Today's High:$1.36
1.11%
Downside
Day's Volatility :1.84%
Upside
0.74%
- 52 Weeks Low:$1.0552 Weeks High:$10.16
22.22%
Downside
52 Weeks Volatility :89.67%
Upside
86.71%
Acrivon Therapeutics Stock Returns
Acrivon Therapeutics, Inc. Key Stats
Check Acrivon Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Acrivon Therapeutics Stock including INR - Dollar returns
The Acrivon Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Acrivon Therapeutics investment value today
Current value as on today
₹19,510
Returns
Returns from Acrivon Therapeutics Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Acrivon Therapeutics Stock
Global Institutional Holdings in Acrivon Therapeutics, Inc.
Name
Holdings %
RA Capital Management, LLC
26.52%
Sands Capital Ventures, LLC
6.75%
Citadel Advisors Llc
6.03%
BlackRock Inc
2.98%
Wellington Management Company LLP
2.82%
Vanguard Group Inc
1.89%
Analyst Recommendation on Acrivon Therapeutics Stock
Buy
87%Buy
12%Hold
0%Sell
Based on 16 Wall street analysts offering stock ratings for Acrivon Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Acrivon Therapeutics Share Price Target
What analysts predicted
Upside of 727.16%
Target:
$11.17
Current:
$1.35
Acrivon Therapeutics share price target is $11.17, a slight Upside of 727.16% compared to current price of $1.35 as per analysts' prediction.
Acrivon Therapeutics Stock Insights
Price Movement
In the last 6 months, ACRV stock has moved down by -74.8%ACRV vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 155.8%
Acrivon Therapeutics Technicals Summary
Sell
Neutral
Buy
Acrivon Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Acrivon Therapeutics, Inc. Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 6.35% | -73.93% | -84.09% | -91.95% | -91.95% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -2.23 | -0.48 | -0.3 | NA | 4.55 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $41.8M | -91.95% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Acrivon Therapeutics, Inc.
Key Management of Acrivon Therapeutics, Inc.
Important FAQs about investing in ACRV Stock from India :
What is Acrivon Therapeutics share price today?
Acrivon Therapeutics share price today is $1.35 as on at the close of the market. Acrivon Therapeutics share today touched a day high of $1.36 and a low of $1.34.
What is the 52 week high and 52 week low for Acrivon Therapeutics share?
Acrivon Therapeutics share touched a 52 week high of $10.16 and a 52 week low of $1.05. Acrivon Therapeutics stock price today i.e. is closed at $1.35, lower by 86.71% versus the 52 week high.
How to invest in Acrivon Therapeutics Stock (ACRV) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Acrivon Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Acrivon Therapeutics Shares that will get you 1.1111 shares as per Acrivon Therapeutics share price of $1.35 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Acrivon Therapeutics Stock (ACRV) from India?
Indian investors can start investing in Acrivon Therapeutics (ACRV) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Acrivon Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Acrivon Therapeutics share’s latest price of $1.35 as on August 30, 2025 at 1:29 am IST, you will get 7.4074 shares of Acrivon Therapeutics. Learn more about
fractional shares .
What are the returns that Acrivon Therapeutics has given to Indian investors in the last 5 years?
Acrivon Therapeutics stock has given -91.95% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
Cassava Sciences Inc$2.29
-3.78%
Collegium Pharmaceutical Inc$38.81
+1.2%
Axogen, Inc.$16.12
-0.62%
Rain Oncology Inc$3.84
-0.26%
- Scilex Holding Co
$17.84
-2.14%
Airsculpt Technologies$6.46
-3.0%
Mesoblast$13.81
-13.42%
Staar Surgical Co$27.33
-0.26%
Corbus Pharmaceuticals Holdings, Inc.$9.39
-5.15%